Clearly, future research should focus on validation of the putative pathogenic role of this gene in PCC predisposition and tumorigenesis using knockout experiments, in vitro cell line experiments and the genotyping of more PCC families for REXO2 mutations. Here, REXO2 is linked to adrenal gland pheochromocytoma.